NasdaqCM - Delayed Quote USD
Fortress Biotech, Inc. (FBIOP)
8.90
-0.23
(-2.47%)
At close: June 10 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 14.53M | 19.29M | 85.71M | 124.06M |
| Low Estimate | 14.44M | 18.7M | 68.34M | 101.36M |
| High Estimate | 14.63M | 19.88M | 103.09M | 146.76M |
| Year Ago Sales | 14.9M | 14.63M | 57.67M | 85.71M |
| Sales Growth (year/est) | -2.43% | 31.83% | 48.61% | 44.74% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FBIOP | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.45% | 7.54% | 14.08% |
Related Tickers
ATXI Avenue Therapeutics, Inc.
0.2642
+31.61%
MBIO Mustang Bio, Inc.
1.2700
-1.55%
LPCN Lipocine Inc.
3.3000
-2.08%
ERAS Erasca, Inc.
1.6100
-1.23%
GRCE Grace Therapeutics, Inc.
2.9800
-5.70%
GRTX Galera Therapeutics, Inc.
0.0240
0.00%
ALXO ALX Oncology Holdings Inc.
0.5338
-7.76%
CNTB Connect Biopharma Holdings Limited
0.7950
+1.79%
NRSN NeuroSense Therapeutics Ltd.
2.1300
+12.11%
PMVP PMV Pharmaceuticals, Inc.
1.1900
+12.26%